Status:

ACTIVE_NOT_RECRUITING

Incidence of Acute Laryngeal Injury Following Endotracheal Intubation

Lead Sponsor:

Vanderbilt University Medical Center

Conditions:

Intubation Complication

Eligibility:

All Genders

18+ years

Phase:

PHASE1

PHASE2

Brief Summary

The purpose of this investigation is to delineate the incidence of acute and chronic laryngeal injury following intubation within our health system. In addition, this study seeks to identify risk fact...

Detailed Description

In the United States, 55 000 patients receive care in more than 6 000 intensive care units (ICUs) each day. The most common reason for ICU admission is respiratory failure and the need for a mechanica...

Eligibility Criteria

Inclusion

  • English-speaking
  • Greater than 24 hours and less than 7 days of intubation in the intensive care unit

Exclusion

  • Age under 18 years on admission
  • Patients with anticipated discharge 5 days after extubation
  • Patients who are dependent for activities of daily living (ADLs) in the 30 days prior to admission
  • Patients unable to consent
  • Patients with neck trauma
  • Patients with head and neck malignancies
  • Patients with pre-existing laryngeal or tracheal stenosis
  • Patients with other pre-existing respiratory conditions such as chronic obstructive pulmonary disease (COPD), asthma, neuromuscular dystrophies, cystic fibrosis, bronchiectasis
  • Patients who had been previously intubated for an extended period of time
  • Patients who are pregnant or currently breastfeeding
  • Patients with allergies to study medications
  • Patients with a resting heart rate greater than 100 beats per minute
  • Patients with a prolonged corrected QT (QTc) interval (\>450 msec) or the use of medications that prolong the QTc interval or are associated with Torsades de pointes (with the exception of amiodarone)24
  • Patients with severe hearing impairment documented by audiometric testing

Key Trial Info

Start Date :

August 19 2017

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 30 2026

Estimated Enrollment :

64 Patients enrolled

Trial Details

Trial ID

NCT03250975

Start Date

August 19 2017

End Date

December 30 2026

Last Update

November 3 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Vanderbilt University Medical Center

Nashville, Tennessee, United States, 37232